Product Details

Eziflea 100 mg Spot-on Solution for Medium Dogs

• MA holder: Chanelle Pharmaceuticals Manufacturing Ltd
• VM number: 08749/5172
• Territory: Great Britain
• Aligned product: View aligned product details
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Public Assessment Report
  • View Post Authorisation Assessment
• Authorised from: 02/07/2019
• Authorisation route: National
• Active substances:
  • Imidacloprid
• Target species:
  • Dogs
• Distribution category: AVM-GSL